Top Industry Leaders in the Neurostimulation Devices Market
Boston Scientific acquires NeuroPace for $825 million deal strengthens Boston Scientific's position in the deep brain stimulation (DBS) market, giving them access to NeuroPace's novel RNS® system for epilepsy treatment.
Abbott acquires St. Jude Medical for $30 billion mega-deal expands Abbott's reach in the spinal cord stimulation (SCS) market, adding St. Jude Medical's innovative portfolio of SCS devices to their offerings.
on-invasive brain stimulation for mental health Research is exploring the use of transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for treating conditions like depression and anxiety, offering less invasive alternatives to traditional therapy.
Bioresorbable neurostimulation devices Companies like NeuroPace are developing implants that dissolve over time, potentially reducing risks associated with permanent implant removal.
List of Neurostimulation Devices Key Companies in the Market
- Nevro Corporation
- NeuroPace
- ImThera Medical
- Therapeutics
- LivaNova (Cyberonics)
- SPR Therapeutics
- Autonomic Technologies
- ElectroCore
- NeuroSigma
- Neuros Medical
- Jude Medical
- Neurometrix
- Synapse Biomedical
- Boston Scientific
- BioControl Medical
- Soterix Medical
- Helius Medical
- Abbott
- GiMer Medical
- BlueWind
- Neuronano
- Bioindduction
- MicroTransponder